Diversity and Gender Differences in Treatment

  • Blanca Bolea-Alamanac
Part of the SpringerBriefs in Psychology book series (BRIEFSPSYCHOL)


Pharmacological and psychological research has been dominated by Western-centric cultural and ethnic paradigms. These paradigms are not always gender inclusive and often fail to acknowledge and cater for the existing diversity in the world’s population. This lack of inclusivity has consequences and leads to differential outcomes in mental health in men and women as well as minorities. From a pharmacological point of view the lack of inclusivity may lead to increase in side effects and lack of response to treatment. Multiple strategies can be used to bridge this gap. Promoting the recruitment of equal numbers of men and women in clinical trials, ensuring recruitment of ethnic minorities by engaging these communities and issuing guidelines about inclusivity by research institutions, regulatory bodies and scientific journals are some of the actions required to achieve better mental health for all.


  1. 1.
    Lind, K. E., Gutierrez, E. J., Yamamoto, D. J., Regner, M. F., McKee, S. A., & Tanabe, J. (2017). Sex disparities in substance abuse research: Evaluating 23 years of structural neuroimaging studies. Drug and Alcohol Dependence, 173, 92–98.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Will, T. R., Proano, S. B., Thomas, A. M., Kunz, L. M., Thompson, K. C., Ginnari, L. A., Jones, C. H., Lucas, S. C., Reavis, E. M., Dorris, D. M., & Meitzen, J. (2017). Problems and progress regarding sex bias and omission in neuroscience research. eNeuro, 4(6), ENEURO.0278–ENEU17.2017.CrossRefGoogle Scholar
  3. 3.
    Nielsen, M., Haun, D., Kartner, J., & Legare, C. H. (2017). The persistent sampling bias in developmental psychology: A call to action. Journal of Experimental Child Psychology, 162, 31–38.CrossRefPubMedGoogle Scholar
  4. 4.
    Beery, A. K., & Zucker, I. (2011). Sex bias in neuroscience and biomedical research. Neuroscience and Biobehavioral Reviews, 35(3), 565–572.CrossRefPubMedGoogle Scholar
  5. 5.
    Kong, B. Y., Haugh, I. M., Schlosser, B. J., Getsios, S., & Paller, A. S. (2016). Mind the gap: Sex bias in basic skin research. The Journal of Investigative Dermatology, 136(1), 12–14.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    GAO. (2001). Most drugs withdrawn in recent years had greater health risks for women. Accessed 16 Dec 2018.
  7. 7.
    Phillips, S. P., & Hamberg, K. (2016). Doubly blind: A systematic review of gender in randomised controlled trials. Global Health Action, 9, 29597. Scholar
  8. 8.
    FDA. (1993). Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice. Federal Register, 58(139), 39406–39416.Google Scholar
  9. 9.
    Geller, S. E., Koch, A., Pellettieri, B., & Carnes, M. (2011). Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: Have we made progress? Journal of Women’s Health (2002), 20(3), 315–320.CrossRefGoogle Scholar
  10. 10.
    Geller, S. E., Koch, A. R., Roesch, P., Filut, A., Hallgren, E., & Carnes, M. (2018). The more things change, the more they stay the same: A study to evaluate compliance with inclusion and assessment of women and minorities in randomized controlled trials. Academic Medicine : Journal of the Association of American Medical Colleges, 93(4), 630–635.CrossRefGoogle Scholar
  11. 11.
    Fisher, J. A., & Ronald, L. M. (2010). Sex, gender, and pharmaceutical politics: From drug development to marketing. Gender Medicine, 7(4), 357–370.CrossRefPubMedGoogle Scholar
  12. 12.
    Marazziti, D., Baroni, S., Picchetti, M., Piccinni, A., Carlini, M., Vatteroni, E., Falaschi, V., Lombardi, A., & Dell’Osso, L. (2013). Pharmacokinetics and pharmacodinamics of psychotropic drugs: Effect of sex. CNS Spectrums, 18(3), 118–127.CrossRefPubMedGoogle Scholar
  13. 13.
    Verster, J. C., & Roth, T. (2012). Gender differences in highway driving performance after administration of sleep medication: A review of the literature. Traffic Injury Prevention, 13(3), 286–292.CrossRefPubMedGoogle Scholar
  14. 14.
    Pettinati, H. M., Kampman, K. M., Lynch, K. G., Suh, J. J., Dackis, C. A., Oslin, D. W., & O’Brien, C. P. (2008). Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. Journal of Substance Abuse Treatment, 34(4), 378–390.CrossRefPubMedGoogle Scholar
  15. 15.
    Salvador Sanchez, J., David, M. D., Torrent Seto, A., Martinez Alonso, M., Portella Moll, M. J., Pifarre Paredero, J., Vieta Pascual, E., & Mur Lain, M. (2017). Electroconvulsive therapy clinical database: Influence of age and gender on the electrical charge. Revista de psiquiatria y salud mental, 10(3), 143–148.CrossRefPubMedGoogle Scholar
  16. 16.
    Chen, M. S., Jr., Lara, P. N., Dang, J. H., Paterniti, D. A., & Kelly, K. (2014). Twenty years post-NIH Revitalization Act: Enhancing minority participation in clinical trials (EMPaCT): Laying the groundwork for improving minority clinical trial accrual: Renewing the case for enhancing minority participation in cancer clinical trials. Cancer, 120 Suppl 7, 1091–1096.CrossRefPubMedGoogle Scholar
  17. 17.
    Polo, A. J., Makol, B. A., Castro, A. S., Colon-Quintana, N., Wagstaff, A. E., & Guo, S. (2019). Diversity in randomized clinical trials of depression: A 36-year review. Clinical Psychology Review, 67, 22–35.CrossRefPubMedGoogle Scholar
  18. 18.
    A, L. L., Naranjo, M. E., Rodrigues-Soares, F., Penas, L. E. M., Farinas, H., & Tarazona-Santos, E. (2014). Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations. Expert Opinion on Drug Metabolism & Toxicology, 10(11), 1569–1583.CrossRefGoogle Scholar
  19. 19.
    Cespedes-Garro, C., Fricke-Galindo, I., Naranjo, M. E., Rodrigues-Soares, F., Farinas, H., de Andres, F., Lopez-Lopez, M., Penas-Lledo, E. M., & LL, A. (2015). Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes. Expert Opinion on Drug Metabolism & Toxicology, 11(12), 1893–1905.CrossRefGoogle Scholar
  20. 20.
    Gaedigk, A., Sangkuhl, K., Whirl-Carrillo, M., Klein, T., & Leeder, J. S. (2016). Prediction of CYP2D6 phenotype from genotype across world populations. Genetics in Medicine, 19, 69.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Denisenko, N. P., Sychev, D. A., Sizova, Z. M., Rozhkov, A. V., & Kondrashov, A. V. (2016). Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple eradication therapy in Slavic patients with peptic ulcers: A meta-analysis. Eksperimental’naia i klinicheskaia gastroenterologiia (Experimental & Clinical Gastroenterology), (11), 11–16.Google Scholar
  22. 22.
    Giri, A. K., Khan, N. M., Grover, S., Kaur, I., Basu, A., Tandon, N., Scaria, V., Kukreti, R., Brahmachari, S. K., & Bharadwaj, D. (2014). Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population. Pharmacogenomics, 15(10), 1337–1354.CrossRefPubMedGoogle Scholar
  23. 23.
    Breakey, W. R., & Dunn, G. J. (2004). Racial disparity in the use of ECT for affective disorders. The American Journal of Psychiatry, 161(9), 1635–1641.CrossRefPubMedGoogle Scholar
  24. 24.
    Weindling, P., von Villiez, A., Loewenau, A., & Farron, N. (2016). The victims of unethical human experiments and coerced research under National Socialism. Endeavour, 40(1), 1–6.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Weigmann, K. (2015). The ethics of global clinical trials: In developing countries, participation in clinical trials is sometimes the only way to access medical treatment. What should be done to avoid exploitation of disadvantaged populations? EMBO Reports, 16(5), 566–570.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Sipe, W. E., & Eisendrath, S. J. (2012). Mindfulness-based cognitive therapy: Theory and practice. Canadian Journal of Psychiatry (Revue canadienne de psychiatrie), 57(2), 63–69.CrossRefGoogle Scholar
  27. 27.
    Tao, K. W., Owen, J., Pace, B. T., & Imel, Z. E. (2015). A meta-analysis of multicultural competencies and psychotherapy process and outcome. Journal of Counseling Psychology, 62(3), 337–350.CrossRefPubMedGoogle Scholar
  28. 28.
    Mehl-Madrona, L. (2016). Indigenous knowledge approach to successful psychotherapies with aboriginal suicide attempters. Canadian Journal of Psychiatry (Revue canadienne de psychiatrie), 61(11), 696–699.CrossRefGoogle Scholar
  29. 29.
    Calabria, B., Clifford, A., Rose, M., & Shakeshaft, A. P. (2014). Tailoring a family-based alcohol intervention for Aboriginal Australians, and the experiences and perceptions of health care providers trained in its delivery. BMC Public Health, 14, 322.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Eley, R., & Gorman, D. (2010). Didgeridoo playing and singing to support asthma management in Aboriginal Australians. The Journal of Rural Health, 26(1), 100–104.CrossRefPubMedGoogle Scholar
  31. 31.
    Marquez, D. X., Wilson, R., Aguinaga, S., Vasquez, P., Fogg, L., Yang, Z., Wilbur, J., Hughes, S., & Spanbauer, C. (2017). Regular Latin dancing and health education may improve cognition of late middle-aged and older Latinos. Journal of Aging and Physical Activity, 25(3), 482–489.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Schiff, J. W., & Moore, K. (2006). The impact of the sweat lodge ceremony on dimensions of well-being. American Indian and Alaska Native Mental Health Research (Online), 13(3), 48–69.CrossRefGoogle Scholar
  33. 33.
    Krysinska, K., Batterham, P. J., & Christensen, H. (2017). Differences in the effectiveness of psychosocial interventions for suicidal ideation and behaviour in women and men: A systematic review of randomised controlled trials. Archives of Suicide Research, 21(1), 12–32.CrossRefPubMedGoogle Scholar
  34. 34.
    Kvarstein, E. H., Nordviste, O., Dragland, L., & Wilberg, T. (2017). Outpatient psychodynamic group psychotherapy - outcomes related to personality disorder, severity, age and gender. Personality and Mental Health, 11(1), 37–50.CrossRefPubMedGoogle Scholar
  35. 35.
    Holzinger, A., Floris, F., Schomerus, G., Carta, M. G., & Angermeyer, M. C. (2012). Gender differences in public beliefs and attitudes about mental disorder in western countries: A systematic review of population studies. Epidemiology and Psychiatric Sciences, 21(1), 73–85.CrossRefPubMedGoogle Scholar
  36. 36.
    Seidler, Z. E., Rice, S. M., Ogrodniczuk, J. S., Oliffe, J. L., & Dhillon, H. M. (2018). Engaging men in psychological treatment: A scoping review. American Journal of Men’s Health, 12(6), 1882–1900.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Gross, J. J., & Levenson, R. W. (1997). Hiding feelings: The acute effects of inhibiting negative and positive emotion. Journal of Abnormal Psychology, 106(1), 95–103.CrossRefPubMedGoogle Scholar
  38. 38.
    Kingston, D., & Tough, S. (2014). Prenatal and postnatal maternal mental health and school-age child development: A systematic review. Maternal and Child Health Journal, 18(7), 1728–1741.CrossRefPubMedGoogle Scholar
  39. 39.
    Brummelte, S., & Galea, L. A. (2016). Postpartum depression: Etiology, treatment and consequences for maternal care. Hormones and Behavior, 77, 153–166.CrossRefPubMedGoogle Scholar
  40. 40.
    Eckenrode, J., Campa, M., Luckey, D. W., Henderson, C. R., Jr., Cole, R., Kitzman, H., Anson, E., Sidora-Arcoleo, K., Powers, J., & Olds, D. (2010). Long-term effects of prenatal and infancy nurse home visitation on the life course of youths: 19-year follow-up of a randomized trial. Archives of Pediatrics & Adolescent Medicine, 164(1), 9–15.CrossRefGoogle Scholar
  41. 41.
    Orton, L., Pennington, A., Nayak, S., Sowden, A., White, M., & Whitehead, M. (2016). Group-based microfinance for collective empowerment: A systematic review of health impacts. Bulletin of the World Health Organization, 94(9), 694–704a.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    UN. (2015). The World’s Women 2015, Trends and statistics. Accessed 17 Dec 2018.
  43. 43.
    Committee on Ethics. (2015). ACOG Committee Opinion No. 646: Ethical Considerations for Including Women as Research Participants. Obstetrics and Gynecology, 126(5), e100–e107.CrossRefGoogle Scholar
  44. 44.
    Durant, R. W., Wenzel, J. A., Scarinci, I. C., Paterniti, D. A., Fouad, M. N., Hurd, T. C., & Martin, M. Y. (2014). Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: Enhancing minority participation in clinical trials (EMPaCT). Cancer, 120 Suppl 7, 1097–1105.CrossRefPubMedGoogle Scholar
  45. 45.
    Lewis, M. E., & Myhra, L. L. (2017). Integrated care with indigenous populations: A systematic review of the literature. American Indian and Alaska Native Mental Health Research (Online), 24(3), 88–110.CrossRefGoogle Scholar
  46. 46.
    Holden, K., McGregor, B., Thandi, P., Fresh, E., Sheats, K., Belton, A., Mattox, G., & Satcher, D. (2014). Toward culturally centered integrative care for addressing mental health disparities among ethnic minorities. Psychological Services, 11(4), 357–368.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Benish, S. G., Quintana, S., & Wampold, B. E. (2011). Culturally adapted psychotherapy and the legitimacy of myth: A direct-comparison meta-analysis. Journal of Counseling Psychology, 58(3), 279–289.CrossRefPubMedGoogle Scholar
  48. 48.
    Parra-Cardona, R., Lopez-Zeron, G., Leija, S. G., Maas, M. K., Villa, M., Zamudio, E., Arredondo, M., Yeh, H. H., & Domenech Rodriguez, M. M. (2019). A culturally adapted intervention for Mexican-origin parents of adolescents: The need to overtly address culture and discrimination in evidence-based practice. Family Process, 58(2), 334–352.CrossRefPubMedGoogle Scholar
  49. 49.
    Pan, D., Huey, S. J., Jr., & Hernandez, D. (2011). Culturally adapted versus standard exposure treatment for phobic Asian Americans: Treatment efficacy, moderators, and predictors. Cultural Diversity & Ethnic Minority Psychology, 17(1), 11–22.CrossRefGoogle Scholar
  50. 50.
    Jenkins, E. K., Kothari, A., Bungay, V., Johnson, J. L., & Oliffe, J. L. (2016). Strengthening population health interventions: Developing the CollaboraKTion framework for community-based knowledge translation. Health Research Policy and Systems, 14(1), 65.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Jenkins, E. K., Bungay, V., Patterson, A., Saewyc, E. M., & Johnson, J. L. (2018). Assessing the impacts and outcomes of youth driven mental health promotion: A mixed-methods assessment of the Social Networking Action for Resilience study. Journal of Adolescence, 67, 1–11.CrossRefPubMedGoogle Scholar
  52. 52.
    Jagsi, R., Griffith, K. A., Jones, R. D., Stewart, A., & Ubel, P. A. (2017). Factors associated with success of clinician-researchers receiving career development awards from the National Institutes of Health: A Longitudinal Cohort Study. Academic Medicine: Journal of the Association of American Medical Colleges, 92(10), 1429–1439.CrossRefGoogle Scholar
  53. 53.
    Carnes, M., & Bairey Merz, C. N. (2017). Women are less likely than men to be full professors in cardiology: Why does this happen and how can we fix it? Circulation, 135(6), 518–520.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Kafer, J., Betancourt, A., Villain, A. S., Fernandez, M., Vignal, C., Marais, G. A. B., & Tenaillon, M. I. (2018). Progress and prospects in gender visibility at SMBE annual meetings. Genome Biology and Evolution, 10(3), 901–908.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Author(s) 2019

Authors and Affiliations

  • Blanca Bolea-Alamanac
    • 1
  1. 1.University of Toronto, Women’s College Hospital and Centre for Addiction and Mental Health, WCH Institute for Health System Solutions and Virtual Care (WIHV)TorontoCanada

Personalised recommendations